From hazard analysis to risk control using rapid methods in microbiology: A practical approach for the food industry

From hazard analysis to risk control using rapid methods in microbiology: A practical approach for the food industry

The prevention of foodborne diseases is one of the main objectives of the health authorities. For this purpose, analytical techniques for detecting and / or quantifying the microbiological contamination of food prior to release on the market are required. The management and control of pathogens of food origin have generally been based on conventional detection methodologies, which do not only consume a lot of time and labor, but also involve high consumer material costs. However, this management perspective has changed over time that the food industry requires effective analytical methods that achieve quick results.

This review covers the historical context of traditional methods and their passage in the latest developments of rapid methods and their implementation in the food sector. Improvements and limitations in the detection of the most relevant pathogens are discussed from a perspective applicable to the current situation in the food industry. Given the efforts and recent developments, fast and accurate methods already used in the food industry will also be affordable and portable and provide connectivity in the near future, which improves decision-making and safety throughout the chain Food. A retrospective epidemiological study describing the characteristics, the incidence rates (IR) and the microbiological etiology of the SCAP in Central Australia.

Adult Patients Admitted to Alice Springs Hospital Intensive Care Unit (ICU) between 2011-2014 which has been included the IDSA / ATS definition of the SCAP. Medical records have been examined and compared between Aboriginal and non-Aboriginal patients. Primary results were an incidence rate and microbiological etiology of SCAP. Secondary results were 30 days mortality and a residence time of the ICU and the hospital (LOS).

 

Plancostomycetes as bacteria associated with the host: a perspective that keeps the promise of their future isolates, imitating their aboriginal environmental niches in clinical microbiology laboratories

 

Traditionally recognized as environmental bacteria, plancostomycetes have recently been linked to human pathology as opportunistic pathogens, providing great interest to clinical microbiologists. However, the absence of appropriate culture media limits our future surveys because no plackctomyte has ever been isolated from patient specimens despite multiple attempts. Several plancostomycetes have no cultivable members and are recognized only by detecting and analyzing the sequence of the arrn genes. Cultivated representatives are tedious slow growth bacteria and most of the time culture on synthetic media.

As a result, the provision of environmental and nutritional conditions such as those existing in natural habitat in natural habitat where non-skin / refractory bacteria can be detected could be an option for their potential isolation. As a result, we have systematically examined the different natural plancostomycete habitats, to examine their nutritional requirements, the physicochemical characteristics of their natural ecological niches, the current methods of cultivation of plackcetes and gaps, from a perspective of data collection. to optimize the conditions and the culture protocols of these tedious bacteria.

Plancptomycetes are prevalent in freshwater, seawater and terrestrial environments, mainly associated with particles or organisms such as macroalgae, marine sponges and lichens, depending on the species and polysaccharides metabolizable by their sulfatasis. Most plancostomycetes are developing in poor nutrient oligotrophic environments with a pH ranging from 3.4 to 11, but some strains can also develop in media rich in nutrients such as M600 / M14. In addition, a variation in seasonality of abundance is observed and flowering occurs in the summer-early autumn, correlated with strong algae growth in marine environments. Most placalcètes are mesophilic, but with some plancostomycetes being thermophilic (50 ° C to 60 ° C).

 From hazard analysis to risk control using rapid methods in microbiology: A practical approach for the food industry
From hazard analysis to risk control using rapid methods in microbiology: A practical approach for the food industry

Mini Review: Clinical Routine Microbiology in the Era of Digital Automation and Health

 

Clinical microbiology laboratories are the first line of infectious disease and antibiotic resistance, including new emerging. Although most clinical laboratories are still based on conventional methods, a cascade of technological change, driven by digital imaging and high-speed sequencing, will revolutionize clinical diagnostics management for direct detection of bacteria and susceptibility testing. rapid antimicrobial. IMPORTANT, such technological advances occur in the golden age of machines learning where computers do not act more passively in the mining of data, but once trained, can also help doctors take Decisions on the optimal diagnosis and administration of treatment.

The additional physical integration potential of new technologies in an automation chain, associated with the software to the automatic learning of data analyzes, is seduced and lead to faster management of infectious diseases. However, if, on the one hand, the technological advancement would have a better performance than conventional methods, on the other side, this evolution disputes clinicians in terms of data interpretation and impact on the whole of the Organization and management of the staff of the hospital.

ELISA kit for HIS (Histamine)

E-EL-0032 1 plate of 96 wells
EUR 452.4
Description: A competitive ELISA kit for quantitative measurement of HIS (Histamine) in samples from Serum, Plasma, Cell supernatant

ELISA kit for General Histamine

EK2448 96 tests
EUR 723.6
Description: Enzyme-linked immunosorbent assay kit for quantification of General Histamine in samples from serum, plasma, tissue homogenates and other biological fluids.

ELISA kit for Mouse Histamine

KTE71604-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Mouse Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Histamine

KTE71604-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Mouse Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse Histamine

KTE71604-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Mouse Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Histamine

KTE62938-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Human Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Histamine

KTE62938-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Human Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Histamine

KTE62938-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Human Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Rat Histamine

KTE101102-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Rat Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Rat Histamine

KTE101102-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Rat Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Rat Histamine

KTE101102-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Rat Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Histamine

20-abx182483
  • EUR 994.80
  • EUR 309.60
  • EUR 661.20
  • 10 g
  • 1 g
  • 5 g

Histamine

HB0500 1g
EUR 151.87

Histamine

HY-B1204 10mM/1mL
EUR 151.2

Histamine

RA22939 100 ul
EUR 490.8

ELISA kit for General HA (Histamine)

ELK7869 1 plate of 96 wells
EUR 446.4
Description: A competitive Inhibition ELISA kit for detection of Histamine from General in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for General HA (Histamine)

ELK8094 1 plate of 96 wells
EUR 446.4
Description: A competitive Inhibition ELISA kit for detection of Histamine from General in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Histamine antibody

20R-HR017 50 uL
EUR 1101.6
Description: Rabbit polyclonal Histamine antibody

Histamine (BSA)

20-abx165751
  • EUR 661.20
  • EUR 292.80
  • EUR 1914.00
  • EUR 777.60
  • EUR 493.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Histamine (OVA)

20-abx165752
  • EUR 661.20
  • EUR 292.80
  • EUR 1914.00
  • EUR 777.60
  • EUR 493.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Histamine-BSA

80-1460 1 mg
EUR 418.8
Description: BSA conjugated Histamine Hapten

Histamine-OVA

80-1461 1 mg
EUR 418.8
Description: OVA conjugated Histamine Hapten

Histamine-OVA

80-1462 1 mg
EUR 418.8
Description: OVA conjugated Histamine Hapten

Histamine 2HCl

B1561-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2.

Histamine 2HCl

B1561-50 50 mg
EUR 153.6
Description: Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2.

Histamine 2HCl

B1561-S Evaluation Sample
EUR 97.2
Description: Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2.

Histamine Phosphate

B1770-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Histamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors.

Histamine Phosphate

B1770-50 50 mg
EUR 153.6
Description: Histamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors.

Histamine antibody

PAab09932 100 ug
EUR 463.2

Histamine diphosphate

HB0502 5g
EUR 76.7

Histamine (phosphate)

HY-A0129 1g
EUR 142.8

Vatalanib Dihydrochloride

2025-25
EUR 366

Vatalanib Dihydrochloride

2025-5
EUR 151.2

1400W dihydrochloride

2055-25
EUR 405.6

1400W dihydrochloride

2055-5
EUR 151.2

GGACK Dihydrochloride

1847-5 5 mg
EUR 382.8
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

PPACK Dihydrochloride

1848-5
EUR 301.2

Puromycin Dihydrochloride

1860-100
EUR 326.4

Puromycin Dihydrochloride

1860-1000
EUR 1554

Puromycin Dihydrochloride

1860-25
EUR 151.2

Puromycin Dihydrochloride

1860-250
EUR 548.4

Puromycin Dihydrochloride

1860-500
EUR 966

Emetine dihydrochloride

1970-250
EUR 430.8

Emetine dihydrochloride

1970-50
EUR 164.4

Norquetiapine dihydrochloride

2362-250
EUR 496.8

Norquetiapine dihydrochloride

2362-50
EUR 170.4

Antipain dihydrochloride

2834-25
EUR 392.4

Antipain dihydrochloride

2834-5
EUR 144

Dorsmorphin dihydrochloride

2835-25
EUR 705.6

Dorsmorphin dihydrochloride

2835-5
EUR 222

Berbamine dihydrochloride

2520-100
EUR 157.2

Berbamine dihydrochloride

2520-500
EUR 444

GGACK Dihydrochloride

A2582-5 5 mg
EUR 282
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin.

PPACK Dihydrochloride

A2588-10 10 mg
EUR 423.6
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM.

PPACK Dihydrochloride

A2588-25 25 mg
EUR 908.4
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM.

PPACK Dihydrochloride

A2588-5 5 mg
EUR 265.2
Description: PPACK Dihydrochloride is the dihydrochloride form of its active component PPACK (D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone), a potent, selective and irreversible inhibitor of thrombin that inhibits human ?-thrombin with inhibition constant Kivalue of 0.24 nM.

AT7867 dihydrochloride

A3199-10 10 mg
EUR 408
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-100 100 mg
EUR 2210.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-5 5 mg
EUR 320.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-5.1 10 mM (in 1mL DMSO)
EUR 344.4
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

AT7867 dihydrochloride

A3199-50 50 mg
EUR 1537.2
Description: IC50: AKT1 32 nM, AKT2 17 nM, AKT3 47 nM, PKA 20 nMThe serine/threonine kinase AKT plays a pivotal role in signal transduction events involved in malignant transformation and chemoresistance and is an attractive target for the development of cancer therapeutics.

Canertinib dihydrochloride

A3276-10 10 mg
EUR 129.6
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Canertinib dihydrochloride

A3276-100 100 mg
EUR 226.8
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Canertinib dihydrochloride

A3276-50 50 mg
EUR 177.6
Description: Canertinib dihydrochloride is a selective inhibitor of Pan-erbB tyrosine kinase with IC50 value of 3.5 nM [1].ErbB receptor family is a member of the receptor tyrosine kinase superfamily and plays an important role in the normal breast development.

Inolitazone dihydrochloride

A3499-5 5 mg
EUR 837.6
Description: Description:IC50 Value: 0.8 nM [1]Inolitazone(RS5444) is a novel high-affinity PPARgamma agonist, which activates PPARgamma with an EC50 about 1/50th that of rosiglitazone and has no effect on RIE cells that do not express PPARgamma.

Alexidine dihydrochloride

A4542-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells.

Alexidine dihydrochloride

A4542-50 50 mg
EUR 220.8
Description: Selective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1) (IC50 = 1.08 ?M in vitro). Stimulates increased insulin secretion by ?-cells in rat pancreatic islets. Displays antitcancer properties in FaDu cells.

Vatalanib Dihydrochloride

20-abx076544
  • EUR 309.60
  • EUR 594.00
  • 10 mg
  • 50 mg

DMPQ Dihydrochloride

20-abx076714
  • EUR 693.60
  • EUR 326.40
  • 25 mg
  • 5 mg

H89 Dihydrochloride

20-abx076747
  • EUR 811.20
  • EUR 360.00
  • 25 mg
  • 5 mg

LDK378 dihydrochloride

A3544-10 10 mg
EUR 186
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-100 100 mg
EUR 331.2
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-5 5 mg
EUR 150
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-5.1 10 mM (in 1mL H2O)
EUR 184.8
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

LDK378 dihydrochloride

A3544-50 50 mg
EUR 240
Description: LDK378 is a highly potent inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase belonging to the superfamily of insulin receptor, with half maximal inhibitory concentration IC50 of 200 pM.

Mibefradil dihydrochloride

A3605-10 10 mg
EUR 315.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride

A3605-25 25 mg
EUR 663.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride

A3605-5 5 mg
EUR 201.6
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Mibefradil dihydrochloride

A3605-50 50 mg
EUR 1195.2
Description: Mibefradil is calcium channel blocker with moderate selectivity for T-type Ca2+ channels displaying IC50 values of 2.7 ?M and 18.6 ?M for T-type and L-type channels respectively. Mibefradil is antihypertensive agent for the treatment of hypertension and chronic angina pectoris.

Pramipexole dihydrochloride

A3733-20 20 mg
EUR 129.6
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Pramipexole dihydrochloride

A3733-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Pramipexole dihydrochloride

A3733-50 50 mg
EUR 157.2
Description: Pramipexole dihydrochloride is a dopamine receptor agonist with selectivity for the D3 receptor (Ki values are 3.9, 3.3, 0.5 and 3.9 nM for D2L, D2S, D3 and D4 receptors respectively). Pramipexole dihydrochloride exhibits negligable affinity for D1 and D5 receptors.

Retigabine dihydrochloride

A3758-10 10 mg
EUR 164.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-100 100 mg
EUR 522
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-5 5 mg
EUR 126
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-50 50 mg
EUR 325.2
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Veliparib dihydrochloride

A3958-10 10 mg
EUR 177.6
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-200 200 mg
EUR 1002
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-5 5 mg
EUR 150
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-5.1 10 mM (in 1mL DMSO)
EUR 139.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-50 50 mg
EUR 421.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Piperazine Dihydrochloride

abx180858-100g 100 g
EUR 276

Pramipexole dihydrochloride

20-abx180860
  • EUR 543.60
  • EUR 276.00
  • EUR 444.00
  • 10 g
  • 1 g
  • 5 g

IT1t dihydrochloride

B5650-10 10 mg
EUR 385.2
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-100 100 mg
EUR 2100
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-25 25 mg
EUR 710.4
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-5 5 mg
EUR 243.6
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-5.1 10 mM (in 1mL DMSO)
EUR 261.6
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

IT1t dihydrochloride

B5650-50 50 mg
EUR 1232.4
Description: IT1t dihydrochloride is a potent antagonist of CXCR4 with IC50 value of 8.0 nM [1]. C-X-C chemokine receptor type 4 (CXCR4) is an ?-chemokine receptor for chemokine CXCL12.

Cystamine dihydrochloride

B5785-5.1 10 mM (in 1mL DMSO)
EUR 129.6

Cystamine dihydrochloride

B5785-50 50 mg
EUR 134.4

Fluphenazine dihydrochloride

B6132-100 100 mg
EUR 180
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons.

Fluphenazine dihydrochloride

B6132-5.1 10 mM (in 1mL DMSO)
EUR 201.6
Description: EC50: 1.24 ?MFluphenazine is a dopamine D1 and D2 receptor inhibitor.Dopamine D1 and D2 receptor immunohistochemistry has been used to study the structure of the adult rat arcuate-median eminence complex, particularly in relation to the tubero-infundibular dopamine neurons.

Dilazep dihydrochloride

B6316-50 50 mg
EUR 321.6

Dimaprit dihydrochloride

B6328-100 100 mg
EUR 321.6

Naloxonazine dihydrochloride

B6366-10 10 mg
EUR 265.2

Naloxonazine dihydrochloride

B6366-50 50 mg
EUR 926.4

Piribedil dihydrochloride

B6557-10 10 mg
EUR 166.8

Piribedil dihydrochloride

B6557-100 100 mg
EUR 258

Piribedil dihydrochloride

B6557-200 200 mg
EUR 404.4

Piribedil dihydrochloride

B6557-5.1 10 mM (in 1mL DMSO)
EUR 180

Piribedil dihydrochloride

B6557-50 50 mg
EUR 223.2

Piribedil dihydrochloride

B6557-500 500 mg
EUR 675.6

Pirenzepine dihydrochloride

B6582-100 100 mg
EUR 160.8

Pirenzepine dihydrochloride

B6582-5.1 10 mM (in 1mL DMSO)
EUR 180

Pirenzepine dihydrochloride

B6582-500 500 mg
EUR 219.6

Telenzepine dihydrochloride

B6606-10 10 mg
EUR 193.2

Telenzepine dihydrochloride

B6606-50 50 mg
EUR 576

DMPQ dihydrochloride

B6642-10 10 mg
EUR 223.2

DMPQ dihydrochloride

B6642-5 5 mg
EUR 184.8

GNTI dihydrochloride

B6669-10 10 mg
EUR 459.6

GNTI dihydrochloride

B6669-50 50 mg
EUR 1746

1400W dihydrochloride

B6730-10 10 mg
EUR 170.4
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

1400W dihydrochloride

B6730-100 100 mg
EUR 873.6
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

1400W dihydrochloride

B6730-50 50 mg
EUR 525.6
Description: 1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase with Kd value of 7 nM [1]. Inducible nitric oxide synthase (iNOS) is an enzyme catalyzing the production of nitric oxide (NO) and is involved in immune response.

Rimcazole dihydrochloride

B6765-10 10 mg
EUR 388.8

Rimcazole dihydrochloride

B6765-50 50 mg
EUR 1453.2

Zimelidine dihydrochloride

B6851-10 10 mg
EUR 212.4

Zimelidine dihydrochloride

B6851-50 50 mg
EUR 711.6

MPP dihydrochloride

B6910-10 10 mg
EUR 381.6

MPP dihydrochloride

B6910-50 50 mg
EUR 1413.6

Linopirdine dihydrochloride

B6916-10 10 mg
EUR 327.6

Linopirdine dihydrochloride

B6916-5 5 mg
EUR 224.4

Mizolastine dihydrochloride

B1116-100 100 mg
EUR 285.6
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Mizolastine dihydrochloride

B1116-200 200 mg
EUR 468
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Mizolastine dihydrochloride

B1116-500 500 mg
EUR 783.6
Description: Mizolastine dihydrochloride is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic reactions.

Flupenthixol dihydrochloride

B7578-50 50 mg
EUR 154.8
Description: MIC: 10-100 ?g/mL in most of the strainsFlupenthixol, introduced in 1965 by Lundbeck, marketed under brand names such asDepixol.Flupenthixolis atypical antipsychoticdrugof thethioxantheneclass.

Puromycin dihydrochloride

B7587-5.1 10 mM (in 1mL H2O)
EUR 142.8
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA.

Puromycin dihydrochloride

B7587-50 50 mg
EUR 157.2
Description: Puromycin dihydrochloride [1] is an analog of aminoacyl-tRNA.

Dexpramipexole dihydrochloride

B2215-25
EUR 548.4

Dexpramipexole dihydrochloride

B2215-5
EUR 183.6

Daclatasvir dihydrochloride

B2224-25
EUR 496.8

Daclatasvir dihydrochloride

B2224-5
EUR 170.4

Netarsudil dihydrochloride

B2387-25
EUR 548.4

Netarsudil dihydrochloride

B2387-5
EUR 183.6

Furamidine dihydrochloride

B2581-25
EUR 652.8

Furamidine dihydrochloride

B2581-5
EUR 210

Bisantrene dihydrochloride

B2736-25 25 mg
EUR 576

Bisantrene dihydrochloride

B2736-5 5 mg
EUR 199.2

Cystamine dihydrochloride

B2982-1 1 g
EUR 132

Cystamine dihydrochloride

B2982-5 5 g
EUR 351.6

Cetirizine dihydrochloride

B2993-100 100mg
EUR 132

Cetirizine dihydrochloride

B2993-500 500mg
EUR 344.4

SA4503 dihydrochloride

B3046-25 25 mg
EUR 612

In this mini-examination, we discuss such technological achievements offering practical examples of their operability, but also their limits and potential problems that their implementation could increase in clinical microbiology laboratories.

Leave A Comment